Copenhagen, Denmark

Tinna Bjoerk Aradottir

USPTO Granted Patents = 16 

Average Co-Inventor Count = 3.4

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2021-2025

Loading Chart...
16 patents (USPTO):Explore Patents

Title: Tinna Bjoerk Aradottir: Innovator in Diabetes Management

Introduction

Tinna Bjoerk Aradottir is a prominent inventor based in Copenhagen, Denmark. She has made significant contributions to the field of diabetes management, particularly in the development of innovative insulin titration algorithms. With a total of 16 patents to her name, Tinna is recognized for her expertise and dedication to improving patient care.

Latest Patents

Tinna's latest patents include an insulin titration algorithm based on patient profiles. This invention provides a device, system, and method for predicting the risk of hypoglycemia and adjusting insulin medicament dose sizes for subjects on pen-based multi-daily injections. The first algorithm computes an initial insulin dose size based on a variety of timestamped blood glucose measurements and insulin injected dose sizes. A risk prediction module utilizes machine learning algorithms to forecast the risk of hypoglycemia based on these measurements, allowing for the calculation of a second insulin dose size that maintains a non-hypoglycemic state. If the second dose size is lower than the first, the initial dose is automatically adjusted and communicated as the recommended dose size to the subject.

Another notable patent involves basal titration with an adaptive target glucose level. This system adjusts long-acting insulin medicament dosages based on a series of timestamped glucose measurements. A titration glucose level is computed as a measure of central tendency of small glucose measurements identified within the timestamped data. The long-acting insulin dosage is then adjusted or maintained based on this obtained titration glucose level.

Career Highlights

Tinna Bjoerk Aradottir works at Novo Nordisk A/S, a leading global healthcare company specializing in diabetes care. Her work at Novo Nordisk has positioned her as a key player in the advancement of diabetes management technologies.

Collaborations

Throughout her career, Tinna has collaborated with notable colleagues such as Henrik Bengtsson and Pete Brockmeier. These collaborations have further enhanced her innovative contributions to the field.

Conclusion

Tinna Bjoerk Aradottir is a trailblazer in the realm of diabetes management, with her innovative patents paving the way for improved patient outcomes. Her work continues to inspire advancements in medical technology and patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…